| ²é¿´: 1050 | »Ø¸´: 5 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
ÀÖÓÆÓÄ¡«Ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
Polycefin£¬Õ⼸¸öµ¥´ÊʲôÒâ˼
|
||
| Polycefin£¬pyridinylmethylene£¬structureecytotoxicitySample Text |
» ²ÂÄãϲ»¶
»¯¹¤Çóµ÷¼Á£¡
ÒѾÓÐ37È˻ظ´
²ÄÁÏÓ뻯¹¤µ÷¼Á
ÒѾÓÐ39È˻ظ´
279ѧ˶ʳƷרҵÇóµ÷¼ÁԺУ
ÒѾÓÐ19È˻ظ´
±¾¿ÆÉúÎïÐÅϢѧ£¬×Ü·Ö362 Çó07 08µ÷¼Á
ÒѾÓÐ7È˻ظ´
ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©×ö¹ý·Ö×ÓʵÑé
ÒѾÓÐ10È˻ظ´
»¯¹¤Ñ§Ë¶294·Ö£¬Çóµ¼Ê¦ÊÕÁô
ÒѾÓÐ18È˻ظ´
Ò»Ö¾Ô¸0703»¯Ñ§ÕÐ61×îÖÕÅÅÃû62»¯Ñ§Çóµ÷¼Á
ÒѾÓÐ33È˻ظ´
266µ÷¼Á
ÒѾÓÐ11È˻ظ´
271Çóµ÷¼Á
ÒѾÓÐ26È˻ظ´
Ò»Ö¾Ô¸085502£¬267·ÖÇóµ÷¼Á
ÒѾÓÐ18È˻ظ´

fjtony163
°æÖ÷ (ÎÄ̳¾«Ó¢)
Ã×Ã×
- Ó¦Öú: 361 (˶ʿ)
- ¹ó±ö: 6.876
- ½ð±Ò: 70610.6
- É¢½ð: 36050
- ºì»¨: 222
- ɳ·¢: 616
- Ìû×Ó: 21912
- ÔÚÏß: 3793.7Сʱ
- ³æºÅ: 1397876
- ×¢²á: 2011-09-11
- רҵ: ÒÅ´«Ñ§Ñо¿Ð¼¼ÊõÓë·½·¨
- ¹ÜϽ: ÂÛÎÄ·Òë
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
zhtear99: ½ð±Ò+2, ¸ÐлÈÈÐÄÓ¦Öú~~~ 2012-11-09 22:46:25
ÀÖÓÆÓÄ¡«: ½ð±Ò+1, ·Ç³£¸Ðл 2012-11-14 14:48:30
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
zhtear99: ½ð±Ò+2, ¸ÐлÈÈÐÄÓ¦Öú~~~ 2012-11-09 22:46:25
ÀÖÓÆÓÄ¡«: ½ð±Ò+1, ·Ç³£¸Ðл 2012-11-14 14:48:30
| ×îºóÒ»¸öÓ¦¸ÃÊǽṹÐÔϸ°û¶¾ÐÔ¡£°É |
3Â¥2012-11-09 20:58:17
zhtear99
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- SFL-EPI: 1
- Ó¦Öú: 147 (¸ßÖÐÉú)
- ¹ó±ö: 0.662
- ½ð±Ò: 3343.9
- É¢½ð: 5190
- ºì»¨: 53
- ɳ·¢: 4
- Ìû×Ó: 1869
- ÔÚÏß: 714.6Сʱ
- ³æºÅ: 1001108
- ×¢²á: 2010-04-19
- ÐÔ±ð: MM
- רҵ: ÉúÎï´ó·Ö×ӽṹÓ빦ÄÜ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ÀÖÓÆÓÄ¡«: ½ð±Ò+3, лл 2012-11-14 14:48:00
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ÀÖÓÆÓÄ¡«: ½ð±Ò+3, лл 2012-11-14 14:48:00
|
pyridinylmethylene£ºÑǼ׻ùßßठPolycefin£ºÒ»ÖÖÉúÎïºÏ³ÉµÄÒ© ÎïµÝËÍϵͳ£¬ÄÉÃ×¹²¾ÛÎÀ´×ÔÓеÀ½âÊÍ£©¡£ The new drug called Polycefin is a molecular biopolymer engineered to interrupt the changes in blood vessels that allow tumors to develop. Its specific targets are genes coding for laminin-411, which influence the thin basement membrane, the structural component of the blood vessels. Polycefin, which is 20 to 30 nanometers in size, acts as a drug itself but also can be engineered to transport other therapeutic molecules, possibly leading to the creation of highly potent, patient-specific treatment options.£¨¼ûÍøÒ³http://www.cedars-sinai.edu/Pati ... Molecular-Oncology/£© structureecytotoxicityÕâ¸öµ¥´Ê¶ÔÂ𣿠|

2Â¥2012-11-09 18:11:01
myIDname
ľ³æ (ÖøÃûдÊÖ)
ÈËÃñ´ó»áÌÃÊ×ϯÇå½à¹¤
- SFL-EPI: 17
- Ó¦Öú: 143 (¸ßÖÐÉú)
- ¹ó±ö: 0.295
- ½ð±Ò: 1700.4
- É¢½ð: 1020
- ºì»¨: 30
- ɳ·¢: 2
- Ìû×Ó: 2540
- ÔÚÏß: 414.7Сʱ
- ³æºÅ: 1586017
- ×¢²á: 2012-01-24
- רҵ: ΢/ÄÉ»úеϵͳ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
zhtear99: ½ð±Ò+2, ¹À¼ÆÒ²ÊǶàдÁ˸öe£¬ºÇºÇ~ 2012-11-09 22:47:11
ÀÖÓÆÓÄ¡«: ½ð±Ò+1, ¸Ðл£¡ 2012-11-14 14:49:09
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
zhtear99: ½ð±Ò+2, ¹À¼ÆÒ²ÊǶàдÁ˸öe£¬ºÇºÇ~ 2012-11-09 22:47:11
ÀÖÓÆÓÄ¡«: ½ð±Ò+1, ¸Ðл£¡ 2012-11-14 14:49:09
|
structureecytotoxicity ¿ÉÄÜÖмä¶àÁ˸öe£¬google scholar¼ìË÷ÎÄÏ×£¬¶àÊÇÒÔstructure-cytotoxicityµÄÐÎʽ³öÏÖ¡£Òâ˼ҲӦ¸ÃÕýÈç3Â¥Ëù˵¡£cytotoxicity£ºtoxic to cells¡£ |

4Â¥2012-11-09 22:17:01
|
6Â¥2012-11-14 14:59:37













»Ø¸´´ËÂ¥